Medico Remedies Ltd

₹ 45.5 -0.85%

05 Jun - close price

medicoremedies.com BSE: 540937 NSE: MEDICO

About

Incorporated in 1994, Medico Remedies Ltd manufactures and sells pharmaceutical formulations^[1]

Key Points

Business Overview:^[1]^[2]
MRL is a pharmaceutical formulation manufacturing and marketing company with focus on antibiotic, anti-infective, beta-lactam penicillin, cephalosporin, anti fungal, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins & supplements, hematinic and other drugs viz. NSAIDS, antihistaminic, anti-diabetics, cardiovascular drugs, antipyretic, analgesic, diuretics, anti-epileptics, antidepressants, antipsychotics, combination drug kits, dry syrups, ointments and cream & gel for various therapeutic segments

Website BSE NSE

Market Cap ₹ 378 Cr.
Current Price ₹ 45.5
High / Low ₹ 57.0 / 30.2
Stock P/E 28.8
Book Value ₹ 9.10
Dividend Yield 0.00 %
ROCE 23.1 %
ROE 19.0 %
Face Value ₹ 2.00

Add ratio to table

Edit ratios

Pros

Company is expected to give good quarter
Company has delivered good profit growth of 38.3% CAGR over last 5 years

Cons

Though the company is reporting repeated profits, it is not paying out dividend
The company has delivered a poor sales growth of 11.0% over past five years.
Earnings include an other income of Rs.5.93 Cr.
Promoter holding has decreased over last 3 years: -12.0%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Figures in Rs. Crores

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
	27.99	31.47	42.36	29.77	41.32	30.80	39.35	39.49	41.30	38.25	52.64	58.68	56.81
	24.82	29.01	39.29	27.04	36.67	27.98	36.94	36.38	34.64	35.43	49.91	54.35	49.66
Operating Profit	3.17	2.46	3.07	2.73	4.65	2.82	2.41	3.11	6.66	2.82	2.73	4.33	7.15
OPM %	11.33%	7.82%	7.25%	9.17%	11.25%	9.16%	6.12%	7.88%	16.13%	7.37%	5.19%	7.38%	12.59%
	0.04	0.31	0.96	0.27	0.58	0.29	0.68	1.43	0.29	0.66	1.72	0.68	2.87
Interest	0.21	0.17	0.18	0.22	0.25	0.18	0.21	0.28	0.49	0.28	0.24	0.39	0.90
Depreciation	0.73	0.71	0.71	0.72	0.74	0.75	0.75	0.76	0.77	0.77	0.73	0.79	0.80
Profit before tax	2.27	1.89	3.14	2.06	4.24	2.18	2.13	3.50	5.69	2.43	3.48	3.83	8.32
Tax %	22.47%	29.63%	22.61%	30.10%	26.89%	27.06%	27.23%	25.14%	23.90%	25.51%	25.86%	25.07%	29.69%
	1.77	1.32	2.43	1.45	3.10	1.58	1.55	2.62	4.34	1.82	2.57	2.87	5.86
EPS in Rs	0.21	0.16	0.29	0.17	0.37	0.19	0.19	0.32	0.52	0.22	0.31	0.35	0.71
Raw PDF

Profit & Loss

Figures in Rs. Crores

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	51	67	54	61	98	89	122	121	140	145	151	206
	48	63	50	58	95	86	117	114	131	132	136	189
Operating Profit	3	4	4	3	3	3	5	7	10	13	15	17
OPM %	6%	5%	7%	6%	3%	3%	4%	6%	7%	9%	10%	8%
	0	0	0	1	2	2	1	2	4	2	3	6
Interest	1	1	1	2	1	1	1	1	1	1	1	2
Depreciation	1	1	1	1	2	2	2	2	3	3	3	3
Profit before tax	1	2	2	2	2	2	4	6	10	11	14	18
Tax %	28%	40%	4%	35%	28%	26%	30%	26%	28%	27%	25%	27%
	1	1	2	1	2	2	3	5	7	8	10	13
EPS in Rs	0.25	0.35	0.25	0.15	0.19	0.20	0.31	0.58	0.87	1.00	1.22	1.58
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Compounded Sales Growth
10 Years:	12%
5 Years:	11%
3 Years:	14%
TTM:	37%

Compounded Profit Growth
10 Years:	28%
5 Years:	38%
3 Years:	22%
TTM:	30%

Stock Price CAGR
10 Years:	%
5 Years:	49%
3 Years:	-18%
1 Year:	-7%

Return on Equity
10 Years:	14%
5 Years:	17%
3 Years:	18%
Last Year:	19%

Balance Sheet

Figures in Rs. Crores

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	2	2	3	4	4	4	4	17	17	17	17	17
Reserves	12	13	13	23	24	26	28	20	27	36	46	59
	8	14	19	13	14	14	15	13	10	8	15	19
	14	17	13	20	35	32	28	28	34	36	43	59
Total Liabilities	36	46	48	59	76	75	76	77	87	96	120	153
	8	7	7	7	12	13	15	18	22	21	21	20
CWIP	0	0	3	4	1	2	0	0	0	0	0	3
Investments	1	1	0	0	0	0	1	0	1	2	2	2
	27	38	39	48	63	60	59	59	64	73	96	129
Total Assets	36	46	48	59	76	75	76	77	87	96	120	153

Cash Flows

Figures in Rs. Crores

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	-3	5	5	1	-11	6	8	2	5	6
	-3	-5	-4	-3	-17	-2	-7	-3	-3	-5
	6	-1	-1	3	18	-6	-2	-0	-1	-1
Net Cash Flow	-0	-0	-0	0	-10	-2	-0	-1	1	1
Free Cash Flow	-4	3	1	-2	-28	3	2	-0	2	1
CFO/OP	-68%	162%	198%	53%	-198%	104%	111%	43%	58%	64%

Ratios

Figures in Rs. Crores

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	53	107	122	102	109	98	82	92	94	125	138	145
Inventory Days	76	63	96	125	74	99	58	76	69	54	90	72
Days Payable	122	106	112	147	149	143	100	113	108	105	117	119
Cash Conversion Cycle	6	64	105	80	33	54	39	54	54	75	111	98
Working Capital Days	21	53	110	88	49	61	50	52	54	74	90	87
ROCE %	10%	11%	10%	9%	8%	8%	10%	15%	21%	21%	21%	23%

Insights

In beta

Mar 2015

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2023

Mar 2024

Mar 2025

Capacity Utilization - Capsules
%

xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx
xx.xx	xx.xx	xx.xx	xx.xx	xx.xx	xx.xx
xx	xx	xx	xx	xx	xx
x.xx	x.xx	x.xx	x.xx	x.xx	x.xx
xxx	xxx	xxx	xxx	xx	xxx
		xx.xx				xx.xx	xx.xx	xx.xx
			xx.xx	xx.xx	xx.xx
			xxx				xxx	xxx
						x	x

Please log in to see hidden values.

Capacity Utilization - Tablets
%

Installed Production Capacity - Capsules
Million units/month

Installed Production Capacity - Dry Syrup
MT/month

Installed Production Capacity - Tablets
Million units/month

Geography-wise Revenue Diversification (Overseas Market)
%

Capacity Utilization - Dry Syrup
%

Total Products in Portfolio
Number of Products

Number of Manufacturing Units
Count

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

4 Recently

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
	73.34%	73.34%	73.34%	73.34%	73.34%	73.34%	66.83%	63.79%	62.59%	61.38%	61.38%	61.38%
	1.19%	1.11%	1.29%	0.29%	0.22%	0.22%	0.39%	0.11%	0.07%	0.30%	0.49%	0.03%
	0.00%	0.00%	0.00%	0.74%	0.97%	0.97%	0.78%	0.01%	0.01%	0.01%	0.00%	0.00%
	25.46%	25.55%	25.36%	25.63%	25.46%	25.47%	32.00%	36.08%	37.33%	38.30%	38.13%	38.60%
No. of Shareholders	5,055	5,264	6,052	10,685	12,902	12,887	14,104	15,424	16,474	18,503	16,562	16,189

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	73.34%	73.34%	73.34%	73.34%	73.34%	73.34%	73.34%	63.79%	61.38%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.53%	0.29%	0.11%	0.03%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.74%	0.01%	0.00%
	26.66%	26.66%	26.66%	26.66%	26.66%	26.15%	25.63%	36.08%	38.60%
No. of Shareholders	204	120	119	107	119	3,287	10,685	15,424	16,189

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Medico Remedies Ltd

Medico Remedies Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Insights

Shareholding Pattern

Documents

Announcements

Annual reports

Credit ratings

Concalls